Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is John, and I will be your conference operator for today. All lines have been placed on mute to prevent any background noise.
Stay updated with breaking news from Robert Spignesi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Thank you for standing by. My name is John, and I will be your conference operator for today. All lines have been placed on mute to prevent any background noise.
The new Rapid Sterility application includes a novel, proprietary test kit that has been developed for use with the Company’s fully automated Growth Direct...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Reports third quarter 2023 total revenue of $6.1 million, representing growth of 30% compared to third quarter 2022Reaffirms full year 2023 total ...
LOWELL, Mass., July 18, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to announce the appointment of Kirk Malloy, Ph.D. as Chair of the Company’s Board of Directors (the “Board”). Dr. Malloy will also Chair the Board’s Compensation Committee. Jeffrey Schwartz, who